Device
TMS (MagVenture MagPro 100 with MagOption)
TMS (MagVenture MagPro 100 with MagOption) is a medical device with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
1(33%)
Phase Distribution
Ph phase_1
1
33%
Ph not_applicable
2
67%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Other(1)
Detailed Status
Not yet recruiting1
Suspended1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 1
Trials by Phase
Phase 11 (33.3%)
N/A2 (66.7%)
Trials by Status
not_yet_recruiting133%
suspended133%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
suspendednot_applicable
Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use Disorder
NCT06577454
not_yet_recruitingphase_1
Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)
NCT06868914
recruitingnot_applicable
Mechanism of Non-invasive Magnetic Stimulation
NCT03394066
Clinical Trials (3)
Showing 3 of 3 trials
NCT06577454Not Applicable
Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use Disorder
NCT06868914Phase 1
Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)
NCT03394066Not Applicable
Mechanism of Non-invasive Magnetic Stimulation
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3